Next Article in Journal
Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing
Previous Article in Journal
Clinical Analysis of Perioperative Outcomes on Neoadjuvant Hormone Therapy before Laparoscopic and Robot-Assisted Surgery for Localized High-Risk Prostate Cancer in a Chinese Cohort
 
 
Article

Article Versions Notes

Curr. Oncol. 2022, 29(11), 8677-8685; https://doi.org/10.3390/curroncol29110684
Action Date Notes Link
article pdf uploaded. 14 November 2022 17:33 CET Version of Record https://www.mdpi.com/1718-7729/29/11/684/pdf-vor
article xml file uploaded 23 November 2022 01:58 CET Original file -
article xml uploaded. 23 November 2022 01:58 CET Update https://www.mdpi.com/1718-7729/29/11/684/xml
article pdf uploaded. 23 November 2022 01:58 CET Updated version of record https://www.mdpi.com/1718-7729/29/11/684/pdf
article html file updated 23 November 2022 01:59 CET Original file -
article html file updated 28 February 2023 23:00 CET Update -
article html file updated 2 March 2023 23:21 CET Update https://www.mdpi.com/1718-7729/29/11/684/html
Back to TopTop